Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Administrative data

Key value for chemical safety assessment

Effects on fertility

Description of key information

No study adressing the fertility endpoint is available for 2-Methyl-5-hydroxyethylaminophenol. However, the results obtained in the 90 days oral repeated dose toxicity study did not show any significant adverse effect on male and female reproductive organs (testes, prostate, seminal vesicles, epididymides, mammary glands, ovaries, uterus and vagina) based on the organ weights, necropsy and micorscopic evaluation findings.

Effect on fertility: via oral route
Endpoint conclusion:
no study available
Effect on fertility: via inhalation route
Endpoint conclusion:
no study available
Effect on fertility: via dermal route
Endpoint conclusion:
no study available

Effects on developmental toxicity

Description of key information

Based on the results of the key study (OECD Guideline 414, GLP, Klimisch 1), the NOAEL oral route (gavage) of maternal toxicity and embryo-/foetotoxicity in rats were both 1000 mg/kg bw/day (highest dose tested).

Effect on developmental toxicity: via oral route
Endpoint conclusion:
no adverse effect observed
Dose descriptor:
NOAEL
1 000 mg/kg bw/day
Study duration:
subacute
Species:
rat
Effect on developmental toxicity: via inhalation route
Endpoint conclusion:
no study available
Effect on developmental toxicity: via dermal route
Endpoint conclusion:
no study available

Toxicity to reproduction: other studies

Additional information

Toxicity to reproduction:

No study adressing the fertility endpoint is available for 2-Methyl-5-hydroxyethylaminophenol.However, the results obtained in the 90 days oral repeated dose toxicity study did not show any significant adverse effect on male and female reproductive organs (testes, prostate, seminal vesicles, epididymides, mammary glands, ovaries, uterus and vagina) based on the organ weights, necropsy and micorscopic evaluation findings.

Developmental toxicity / teratogenicity:

Two Embryo-foetal developmental toxicity studies by the oral route in the rat are available (one key recent and guideline study with a Klimisch 1 quotation and one non-guideline ancient supporting study with a Klimisch 2 quotation). The results of both studies are concordant. In the key study (OECD Guideline 414, GLP, Klimisch 1), 2-Methyl-5-hydroxyethylaminophenol was administred to female Sprague-Dawley rats by gavage at the doses of 100, 300 and 1000 mg/kg bw from day 6 to 19 of gestation. The results of this study showed that 2-Methyl-5-hydroxyethylaminophenol was well tolerated at all the tested doses, and that no signs of toxicity were noted in the pregnant females, on the embryofetal development or on the growth in utero at any dose-level. Based on the results of this key study, the NOAEL of maternal toxicity and embryo-/foetotoxicity in rats were both 1000 mg/kg bw/day.

Justification for classification or non-classification

The available data do not suggest that 2-Methyl-5-hydroxyethylaminophenol should be classified for reproductive toxicity.

Additional information